Fatty Liver Disease: An Epidemic and a Biomarker Solution

CLICK HERE for the Liver Tracker
#liver #fattyliver #liverrecipes #liversymptoms #livertreatment


Marc K. Hellerstein, M.D., Ph.D., President and Chief Scientific Officer of KineMed, discusses the central role of biomarkers developed by KineMed for the response to the epidemic of Fatty Liver Disease to be successful.

More at http://myhealthguide.website/